Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Vroege behandeling van milde tot matige COVID-19 met sotrovimab reduceert risico op progressie
apr 2022 | Pneumonie, Virale infecties